Member Login
  1. Stocks
    2. /
  2. AbbVie (NYSE: ABBV)
    3. /

NYSE:ABBV (AbbVie)

About ABBV

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • AbbVie (NYSE: ABBV) Latest News

    The flag of the United States of America flying in front of the Capitol building
    Investing Articles

    3 top US dividend stocks for value investors to consider in 2024

    | Mark Hartley

    I’m searching far and wide to find the best dividend stocks that money can buy. Do the Americans have more…

    Read more »

    The flag of the United States of America flying in front of the Capitol building
    Investing Articles

    2 great dividend shares I’m buying now

    | Muhammad Cheema

    AbbVie and Coca-Cola are two dividend shares that I like the look of. Let’s take a deeper dive below to…

    Read more »

    The flag of the United States of America flying in front of the Capitol building
    Investing Articles

    2 great dividend shares I’m buying now

    | Muhammad Cheema

    AbbVie and US Bancorp are two dividend shares that have plunged recently. Let’s take a deeper dive below to see…

    Read more »

    Investing Articles

    3 pharma stocks to watch in April

    | Pam Narang

    Pharma stocks are rarely a bad bet in the long term, but risk can vary widely and should be weighed…

    Read more »

    Investing Articles

    Should I Invest In Direct Line Insurance Group PLC, Mountview Estates plc And Shire PLC Now?

    | Kevin Godbold

    Can Direct Line Insurance Group PLC (LON: DLG), Mountview Estates plc (LON: MTVW) and Shire PLC (LON: SHP) still deliver…

    Read more »

    Investing Articles

    Is Shire PLC A Buy After AbbVie Inc Withdraws Takeover Offer?

    | Roland Head

    Shire PLC (LON:SHP) is starting to look attractive again, now that the AbbVie Inc (NYSE:ABBV) deal is over.

    Read more »

    Investing Videos

    A Closer Look At Shire PLC

    | Nate Weisshaar

    VIDEO: Two Fools take a closer look at Shire PLC (LON:SHP).

    Read more »

    Investing Articles

    Why AbbVie Inc Is Buying Shire PLC

    | Prabhat Sakya

    AbbVie Inc (NYSE:ABBV) and Shire PLC (LON:SHP) have strongly complementary research portfolios.

    Read more »

    Company Comment

    Shire PLC Accepts £32bn Takeover By AbbVie Inc

    | Sam Robson

    Shire PLC (LON:SHP) agrees to £32bn AbbVie Inc (NYSE: ABBV) deal.

    Read more »

    Investing Articles

    One Reason Why AstraZeneca plc Is A Risky Bet

    | Alessandro Pasetti

    It's tough for AstraZeneca plc (LON:AZN) shareholders, argues Alessandro Pasetti.

    Read more »

    Company Comment

    Shire PLC Willing To Recommend £32bn Bid From AbbVie Inc

    | Mark Stones

    There's a Friday deadline for AbbVie Inc (NYSE: ABBV) to decide whether to make firm offer for Shire PLC (LON:…

    Read more »

    Investing Articles

    AbbVie Inc’s Raised Bid Confirms My Shire PLC Sell Rating

    | Roland Head

    Shire PLC (LON:SHP) shares are sliding following AbbVie Inc (NYSE: ABBV)'s increased bid, confirming this Fool's previous sell call.

    Read more »